文献速递乳腺癌

18F-FDG PET/CT代谢参数与乳腺癌临床病理特征的关系

[The relationship between (18)F-FDG PET/CT metabolic parameters and clinicopathological features of breast cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2017-01-01

该回顾性研究分析了78例术前接受18F-FDG PET/CT的乳腺癌患者,测量原发灶SUVmax、SUVmean、MTV、TLG及转移淋巴结最高SUVmax,发现原发灶代谢参数(尤其TLG)与病理分期、T分期、淋巴结侵犯、Ki-67及最大径相关,转移淋巴结SUVmax与原发灶代谢参数和临床分期正相关。

要点

  • 原发灶SUVmax、MTV、TLG在不同病理分期、T分期及有无淋巴结侵犯间差异有统计学意义(均P<0.05)。
  • TLG与Ki-67、最大径、T分期及临床分期的相关系数最高。
  • 转移淋巴结SUVmax与原发灶代谢参数、T分期和临床分期均正相关(均P<0.05)。

核心结论

  • 18F-FDG PET/CT代谢参数尤其是TLG与乳腺癌临床病理特征相关性最高。
  • 转移淋巴结SUVmax与原发灶代谢参数及临床分期正相关。

研究设计与样本

  • 回顾性分析78例术前接受18F-FDG PET/CT的乳腺癌患者临床资料。
  • 以40% SUVmax为阈值,在横断面、矢状面和冠状面测量原发灶SUVmax、SUVmean、MTV并计算TLG,同时测量转移淋巴结最高SUVmax。

主要发现

  • 78个原发灶SUVmax、SUVmean、MTV、TLG及最大径分别为6.64(1.85,22.79)、3.88(1.30,11.42)、13.36(1.66,129.08)cm³、47.92(2.85,443.28)g和2.35(1.23,9.80)cm,转移淋巴结SUVmax为5.12(2.38,14.32)。
  • 原发灶SUVmax、MTV、TLG在不同病理分期、T分期及有无淋巴结侵犯间差异均有统计学意义(均P<0.05)。
  • ER阴性患者仅TLG高于ER阳性患者(P<0.05),PR阴性患者TLG和MTV均高于PR阳性患者(均P<0.05),HER-2阴性与阳性患者间各代谢参数差异均无统计学意义(均P>0.05)。
  • 原发灶SUVmax、MTV、TLG与Ki-67及最大径均正相关(均P<0.05),TLG相关系数最高;SUVmax、SUVmean、MTV、TLG均与T分期正相关(均P<0.05),TLG相关系数最高;各参数与N分期均无相关性(均P>0.05);仅TLG与临床分期正相关(P<0.05)。
  • 转移淋巴结SUVmax分别与原发灶代谢参数、T分期和临床分期正相关(均P<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the relationship between metabolic parameters of primary lesion and clinicopathological features of patients with breast cancer. Methods: Clinical data of 78 patients with breast cancer undergone (18)F-FDG PET/CT before surgery was retrospectively analyzed. SUVmax, SUVmean and metabolic tumor volume (MTV) of primary lesions were measured by horizontal, sagittal and coronal position volume section with a threshold of 40% SUVmax. TLG was calculated and the highest SUVmax among metastatic lymph nodes was measured. Results: SUVmax, SUVmean, MTV, TLG and the maximum diameter of 78 primary lesions were 6.64(1.85, 22.79), 3.88(1.30, 11.42), 13.36(1.66, 129.08)cm(3,) 47.92(2.85, 443.28)g and 2.35(1.23, 9.80)cm, respectively. SUVmax of metastatic lymph node was 5.12(2.38, 14.32). There were statistically significant differences of primary lesion metabolic parameters (SUVmax, MTV, TLG) in different pathological stages, T stages, with or without lymph node invasion (all P<0.05). Only TLG of ER negative patients was higher than that of ER positive patients (P<0.05). TLG, MTV of PR negative patients were higher than that of PR positive patients (both P<0.05). No significant differences of metabolic parameters were found between HER-2 negative and positive patients (all P>0.05). SUVmax, MTV, TLG of primary lesion were positively associated with Ki-67 and the maximum diameter (all P<0.05), and the correlation coefficient of TLG was the highest. SUVmax, SUVmean, MTV and TLG were all positively associated with T stage (all P<0.05), and the correlation coefficient of TLG was the highest. None of the parameters had correlation with N stage(all P>0.05). Only TLG had positive correlation with clinical stage (P<0.05). SUVmax of metastatic lymph node was positively associated with metabolic parameters of primary lesion, T stage and clinical stage, respectively (all P<0.05). Conclusions: (18)F-FDG PET/CT metabolic parameters, especially TLG has the highest correlation with clinicopathological features of breast cancer. SUVmax of metastatic lymph node was positively associated with metabolic parameters of primary lesion and clinical stage.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Tang B, Zhang Y, Zhou J, et al. [The relationship between (18)F-FDG PET/CT metabolic parameters and clinicopathological features of breast cancer]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28550668. doi:10.3760/cma.j.issn.0253-3766.2017.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。